CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade DexCom, Inc. - DXCM CFD

    116.11
    1.88%
    0.22
    Low: 115.76
    High: 117.47
    Market Trading Hours* (UTC) Open now
    Closes on Tuesday at 21:00

    Mon - Fri: 14:30 - 21:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.22
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Dexcom Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 118.17
    Open* 116.8
    1-Year Change* -1.06%
    Day's Range* 115.76 - 117.47
    52 wk Range 74.75-139.55
    Average Volume (10 days) 4.70M
    Average Volume (3 months) 111.72M
    Market Cap 42.10B
    P/E Ratio 123.40
    Shares Outstanding 386.37M
    Revenue 3.40B
    EPS 0.88
    Dividend (Yield %) N/A
    Beta 1.18
    Next Earnings Date Feb 7, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 4, 2023 118.17 2.74 2.37% 115.43 118.65 115.43
    Dec 1, 2023 116.52 2.36 2.07% 114.16 117.38 112.51
    Nov 30, 2023 115.48 -0.61 -0.53% 116.09 117.10 114.63
    Nov 29, 2023 116.11 3.32 2.94% 112.79 117.15 112.79
    Nov 28, 2023 112.10 -0.92 -0.81% 113.02 113.53 111.05
    Nov 27, 2023 113.84 1.90 1.70% 111.94 114.96 111.94
    Nov 24, 2023 112.84 2.36 2.14% 110.48 113.70 110.06
    Nov 22, 2023 110.72 1.27 1.16% 109.45 111.95 109.04
    Nov 21, 2023 108.85 0.14 0.13% 108.71 109.54 107.40
    Nov 20, 2023 108.87 4.82 4.63% 104.05 109.09 104.05
    Nov 17, 2023 104.90 0.40 0.38% 104.50 106.62 103.82
    Nov 16, 2023 104.70 2.76 2.71% 101.94 105.12 101.94
    Nov 15, 2023 102.02 0.82 0.81% 101.20 104.06 100.69
    Nov 14, 2023 101.27 1.78 1.79% 99.49 103.70 99.06
    Nov 13, 2023 98.27 1.10 1.13% 97.17 100.39 94.49
    Nov 10, 2023 93.99 1.00 1.08% 92.99 94.97 91.38
    Nov 9, 2023 92.30 0.03 0.03% 92.27 95.09 91.61
    Nov 8, 2023 92.68 -2.57 -2.70% 95.25 95.25 91.36
    Nov 7, 2023 95.14 0.02 0.02% 95.12 97.45 94.91
    Nov 6, 2023 94.75 -2.68 -2.75% 97.43 98.75 94.26

    DexCom, Inc. Events

    Time (UTC) Country Event
    Wednesday, February 7, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 Dexcom Inc Earnings Release
    Q4 2023 Dexcom Inc Earnings Release

    Forecast

    -

    Previous

    -
    Thursday, April 25, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q1 2024 Dexcom Inc Earnings Release
    Q1 2024 Dexcom Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 2909.8 2448.5 1926.7 1476 1031.6
    Revenue 2909.8 2448.5 1926.7 1476 1031.6
    Cost of Revenue, Total 1012.8 739.9 622.2 530.4 367.7
    Gross Profit 1897 1708.6 1304.5 945.6 663.9
    Total Operating Expense 2518.6 2182.8 1627.2 1333.7 1217.9
    Selling/General/Admin. Expenses, Total 1000.2 806.8 618.2 515.7 432.8
    Research & Development 484.2 604.2 359.9 273.5 417.4
    Operating Income 391.2 265.7 299.5 142.3 -186.3
    Interest Income (Expense), Net Non-Operating -0.4 -8.9 -1.6 -38.1 59.8
    Other, Net
    Net Income Before Taxes 390.8 256.8 297.9 104.2 -126.5
    Net Income After Taxes 341.2 216.9 549.7 101.1 -127.5
    Net Income Before Extra. Items 341.2 216.9 549.7 101.1 -127.5
    Net Income 341.2 216.9 549.7 101.1 -127.1
    Income Available to Common Excl. Extra. Items 341.2 216.9 549.7 101.1 -127.5
    Income Available to Common Incl. Extra. Items 341.2 216.9 549.7 101.1 -127.1
    Diluted Net Income 341.2 216.9 549.7 101.1 -127.1
    Diluted Weighted Average Shares 427.5 428.8 420.4 369.2 352.8
    Diluted EPS Excluding Extraordinary Items 0.79813 0.50583 1.30756 0.27384 -0.36139
    Dividends per Share - Common Stock Primary Issue
    Diluted Normalized EPS 0.83101 0.60964 1.36632 0.33848 -0.35145
    Total Extraordinary Items 0 0.4
    Unusual Expense (Income) 13.9 28.2 24.4 14.1
    Depreciation / Amortization 7.5 3.7 2.5
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total revenue 975 871.3 741.5 815.2 769.6
    Revenue 975 871.3 741.5 815.2 769.6
    Cost of Revenue, Total 351.7 324.9 278.9 260 275.4
    Gross Profit 623.3 546.4 462.6 555.2 494.2
    Total Operating Expense 769.5 743.2 694.3 689.8 622.1
    Selling/General/Admin. Expenses, Total 284.7 297.3 294.6 297.8 234.6
    Research & Development 131.4 119.3 119 116.3 110.3
    Operating Income 205.5 128.1 47.2 125.4 147.5
    Interest Income (Expense), Net Non-Operating 1 31.2 17.3 7.8 -1.3
    Net Income Before Taxes 240.4 159.3 64.5 133.2 146.2
    Net Income After Taxes 120.7 115.9 48.6 91.8 101.2
    Net Income Before Extra. Items 120.7 115.9 48.6 91.8 101.2
    Net Income 120.7 115.9 48.6 91.8 101.2
    Income Available to Common Excl. Extra. Items 120.7 115.9 48.6 91.8 101.2
    Income Available to Common Incl. Extra. Items 120.7 115.9 48.6 91.8 101.2
    Diluted Net Income 120.7 115.9 48.6 91.8 101.2
    Diluted Weighted Average Shares 426.8 431.5 418.5 426 425.8
    Diluted EPS Excluding Extraordinary Items 0.2828 0.2686 0.11613 0.21549 0.23767
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS 0.2828 0.2686 0.11613 0.23798 0.23767
    Unusual Expense (Income) 13.9
    Depreciation / Amortization 1.7 1.7 1.8 1.8 1.8
    Other, Net 33.9
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 3668.8 3684.4 3424.8 1969.4 1699.5
    Cash and Short Term Investments 2456.2 2731.2 2707.7 1533.3 1385.6
    Cash & Equivalents 642.3 1052.6 817.6 446.2 1137
    Short Term Investments 1813.9 1678.6 1890.1 1087.1 248.6
    Total Receivables, Net 713.3 514.3 428.5 286.3 226.7
    Accounts Receivable - Trade, Net 713.3 514.3 428.5 286.3 226.7
    Total Inventory 306.7 357.3 234.7 119.8 70.7
    Prepaid Expenses 192.6 81.6 53.9 30 16.5
    Total Assets 5391.7 4933.3 4290.5 2395 1916
    Property/Plant/Equipment, Total - Net 1135.6 889.9 608.6 392.8 183.1
    Property/Plant/Equipment, Total - Gross 1498.8 1121.4 762.8 497.8 262.9
    Accumulated Depreciation, Total -363.2 -231.5 -154.2 -105 -79.8
    Goodwill, Net 25.7 26.5 19.3 18.6 18.7
    Intangibles, Net 173.3 31.5
    Other Long Term Assets, Total 388.3 301 237.8 14.2 14.7
    Total Current Liabilities 1839.3 720.8 614.1 360.2 222.4
    Accounts Payable 237.9 189.4 163.3 102.3 75.5
    Accrued Expenses 814.5 514.3 439.8 255.6 144
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 776.8 8.8 0.6
    Other Current Liabilities, Total 10.1 17.1 2.2 1.7 2.9
    Total Liabilities 3259.9 2891.2 2464 1512.4 1252.7
    Total Long Term Debt 1257.3 2038.8 1721.2 1074.1 1017.6
    Long Term Debt 1197.7 1981.8 1667.2 1059.7 1010.3
    Capital Lease Obligations 59.6 57 54 14.4 7.3
    Other Liabilities, Total 158.4 125.7 128.7 78.1 12.7
    Total Equity 2131.8 2042.1 1826.5 882.6 663.3
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.4 0.1 0.1 0.1 0.1
    Additional Paid-In Capital 2258.1 2109 2125.3 1675.9 1560.6
    Retained Earnings (Accumulated Deficit) 479.9 138.7 -202.1 -695.7 -798.9
    Other Equity, Total -11.6 0.5 3.2 2.3 1.5
    Total Liabilities & Shareholders’ Equity 5391.7 4933.3 4290.5 2395 1916
    Total Common Shares Outstanding 386.3 388 384.4 366.4 360
    Treasury Stock - Common -595 -206.2 -100 -100 -100
    Deferred Income Tax 4.9 5.9
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 4698.4 5002.9 3767.4 3668.8 3398.5
    Cash and Short Term Investments 3240.3 3636.2 2567 2456.2 2371.9
    Cash & Equivalents 643.7 1194.9 623.2 642.3 698.1
    Short Term Investments 2596.6 2441.3 1943.8 1813.9 1673.8
    Total Receivables, Net 785.7 755.6 652.5 713.3 564.1
    Accounts Receivable - Trade, Net 785.7 750.6 636.8 713.3 564.1
    Total Inventory 498.6 421.1 366 306.7 311
    Prepaid Expenses 173.8 190 181.9 192.6 151.5
    Total Assets 6596.2 6820.7 5515.9 5391.7 4899.2
    Property/Plant/Equipment, Total - Net 1152.3 1153.9 1153.5 1135.6 1075.6
    Property/Plant/Equipment, Total - Gross 1618.6 1582.2 1548 1498.8 1414.1
    Accumulated Depreciation, Total -466.3 -428.3 -394.5 -363.2 -338.5
    Goodwill, Net 25.3 25.8 25.7 25.7 24.7
    Other Long Term Assets, Total 575.7 483.9 405.7 388.3 376
    Total Current Liabilities 1678.6 2069.7 1865 1839.3 900.5
    Accounts Payable 242.4 269.1 266.2 237.9 198.1
    Accrued Expenses 1303 1017.8 816 818.7 699.7
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 9 9 9.6 10.1 2.7
    Total Liabilities 4328.3 4720.3 3282.9 3259.9 3074.7
    Total Long Term Debt 2490.3 2489.1 1257.7 1257.3 2029.2
    Long Term Debt 2432.4 2430.6 1198.5 1197.7 1968.8
    Capital Lease Obligations 57.9 58.5 59.2 59.6 60.4
    Other Liabilities, Total 154.8 156.7 155.4 158.4 139.7
    Total Equity 2267.9 2100.4 2233 2131.8 1824.5
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.4 0.4 0.4 0.4 0.4
    Additional Paid-In Capital 3618 2269 2305.6 2258.1 2072.1
    Retained Earnings (Accumulated Deficit) 765.1 644.4 528.5 479.9 388.1
    Treasury Stock - Common -2080 -784.1 -595 -595 -595
    Other Equity, Total -35.6 -29.3 -6.5 -11.6 -41.1
    Total Liabilities & Shareholders’ Equity 6596.2 6820.7 5515.9 5391.7 4899.2
    Total Common Shares Outstanding 386.4 386.1 387.6 386.3 386.2
    Intangibles, Net 144.5 154.2 163.6 173.3 24.4
    Deferred Income Tax 4.6 4.8 4.8 4.9 5.3
    Current Port. of LT Debt/Capital Leases 124.2 773.8 773.2 772.6
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 341.2 154.7 493.6 101.1 -127.1
    Cash From Operating Activities 669.5 442.5 475.6 314.5 123.2
    Cash From Operating Activities 155.9 102 67.1 48.7 29.1
    Non-Cash Items 167.3 322.7 213 158.6 262.1
    Cash Taxes Paid 114.2 16.8 3.6 4.8 2.3
    Cash Interest Paid 12.2 11.6 10.6 10.4 3.6
    Changes in Working Capital 26.7 -132 -20.8 6.1 -40.9
    Cash From Investing Activities -521.5 -216.1 -1018 -1015.2 -139.8
    Capital Expenditures -364.8 -389.2 -199 -180 -67.1
    Other Investing Cash Flow Items, Total -156.7 173.1 -819 -835.2 -72.7
    Cash From Financing Activities -552.5 10.4 912.1 10.7 710.4
    Issuance (Retirement) of Stock, Net -535.2 20.3 15.3 11.9 94.6
    Issuance (Retirement) of Debt, Net 0 0 906.2 0 617.7
    Net Change in Cash -410.3 235.4 371.8 -690.7 695.6
    Foreign Exchange Effects -5.8 -1.4 2.1 -0.7 1.8
    Financing Cash Flow Items -17.3 -9.9 -9.4 -1.2 -1.9
    Deferred Taxes -21.6 -4.9 -277.3
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 48.6 341.2 249.4 148.2 97.3
    Cash From Operating Activities 155.4 669.5 537 243.8 71
    Cash From Operating Activities 41.6 155.9 119.6 80.4 36.8
    Deferred Taxes -9.3 -21.6 -53.6 -19.8 0.1
    Non-Cash Items 23 167.3 128.9 80.7 34.3
    Changes in Working Capital 51.5 26.7 92.7 -45.7 -97.5
    Cash From Investing Activities -186.7 -521.5 -327.4 -556.7 -411.8
    Capital Expenditures -74.7 -364.8 -301.3 -193.1 -101.6
    Other Investing Cash Flow Items, Total -112 -156.7 -26.1 -363.6 -310.2
    Cash From Financing Activities 11.2 -552.5 -551.5 1 5.3
    Financing Cash Flow Items -1.1 -17.3 -16.3 -9.1 -4.8
    Issuance (Retirement) of Stock, Net 12.3 -535.2 -535.2 10.1 10.1
    Foreign Exchange Effects 1.1 -5.8 -12.6 -5.3 -1
    Net Change in Cash -19 -410.3 -354.5 -317.2 -336.5
    Issuance (Retirement) of Debt, Net 0
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 11.4173 44113549 184884 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 5.5734 21534123 434245 2023-06-30 LOW
    Baillie Gifford & Co. Investment Advisor 4.3283 16723298 -434201 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.2816 16543092 399376 2023-06-30 LOW
    Sands Capital Management, LLC Investment Advisor 3.3913 13103127 -635841 2023-06-30 LOW
    Fidelity Management & Research Company LLC Investment Advisor 2.6614 10282913 -185843 2023-06-30 LOW
    JP Morgan Asset Management Investment Advisor 2.5805 9970251 1766071 2023-06-30 LOW
    Capital Research Global Investors Investment Advisor 2.3595 9116546 -158069 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.2148 8557578 274915 2023-06-30 LOW
    Nuveen LLC Pension Fund 1.9057 7363058 54892 2023-06-30 LOW
    Jennison Associates LLC Investment Advisor/Hedge Fund 1.8848 7282187 17192 2023-06-30 LOW
    Invesco Capital Management (QQQ Trust) Investment Advisor 1.7102 6607873 38672 2023-09-30 LOW
    American Century Investment Management, Inc. Investment Advisor/Hedge Fund 1.3341 5154492 679071 2023-06-30 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 1.2821 4953819 768128 2023-06-30 LOW
    William Blair & Company, L.L.C. (Research) Research Firm 1.1475 4433499 77048 2023-06-30 LOW
    Invesco Advisers, Inc. Investment Advisor 1.1266 4352783 173122 2023-06-30 LOW
    ClearBridge Investments, LLC Investment Advisor/Hedge Fund 1.0522 4065548 -56084 2023-06-30 LOW
    Capital World Investors Investment Advisor 1.0018 3870567 124197 2023-06-30 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.9631 3721104 403408 2022-12-31 LOW
    Macquarie Investment Management Investment Advisor 0.8067 3116766 -168810 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    DexCom Company profile

    DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
    Industry: Medical Equipment, Supplies & Distribution (NEC)

    6340 Sequence Dr
    SAN DIEGO
    CALIFORNIA 92121
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Gold

    2,013.92 Price
    -0.660% 1D Chg, %
    Long position overnight fee -0.0200%
    Short position overnight fee 0.0118%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    Oil - Crude

    73.73 Price
    +0.330% 1D Chg, %
    Long position overnight fee -0.0201%
    Short position overnight fee -0.0018%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    US100

    15,892.50 Price
    +0.330% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    XRP/USD

    0.62 Price
    -1.720% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading